No single ticker was named. Biotech ETFs are one way for retail investors to get exposure. Not a recommendation.
Flaws in standard microcap benchmark IWC
The standard iShares Micro-Cap ETF benchmark is heavily flawed due to poor quality, non-profitable companies, and sector concentration.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day — no card required.